Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

NCT06991348 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Tegoprazan
DRUG: Pantoprazole

Sponsor

Carnot Laboratories